These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 35162967)

  • 21. Abelmoschus esculentus subfractions ameliorate hepatic lipogenesis and lipid uptake via regulating dipeptidyl peptidase-4-With improving insulin resistance.
    Peng CH; Ker YB; Li HH; Tsou SH; Lin CL; Huang CN
    PLoS One; 2022; 17(3):e0265444. PubMed ID: 35290413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes.
    Choi YJ; Shin HS; Choi HS; Park JW; Jo I; Oh ES; Lee KY; Lee BH; Johnson RJ; Kang DH
    Lab Invest; 2014 Oct; 94(10):1114-25. PubMed ID: 25111690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit?
    Neokosmidis G; Cholongitas E; Tziomalos K
    World J Gastroenterol; 2021 Oct; 27(39):6522-6526. PubMed ID: 34754150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of
    Park M; Kang C; Lee HJ
    Curr Issues Mol Biol; 2021 Apr; 43(1):21-35. PubMed ID: 33925122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitexin alleviates non-alcoholic fatty liver disease by activating AMPK in high fat diet fed mice.
    Inamdar S; Joshi A; Malik S; Boppana R; Ghaskadbi S
    Biochem Biophys Res Commun; 2019 Oct; 519(1):106-112. PubMed ID: 31472955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems.
    Ross TT; Crowley C; Kelly KL; Rinaldi A; Beebe DA; Lech MP; Martinez RV; Carvajal-Gonzalez S; Boucher M; Hirenallur-Shanthappa D; Morin J; Opsahl AC; Vargas SR; Bence KK; Pfefferkorn JA; Esler WP
    Cell Mol Gastroenterol Hepatol; 2020; 10(4):829-851. PubMed ID: 32526482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inhibition of oleic acid induced hepatic lipogenesis and the promotion of lipolysis by caffeic acid via up-regulation of AMP-activated kinase.
    Liao CC; Ou TT; Huang HP; Wang CJ
    J Sci Food Agric; 2014 Apr; 94(6):1154-62. PubMed ID: 24027117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naringin improves lipid metabolism in a tissue-engineered liver model of NAFLD and the underlying mechanisms.
    Zhang X; Zhang Y; Gao W; Guo Z; Wang K; Liu S; Duan Z; Chen Y
    Life Sci; 2021 Jul; 277():119487. PubMed ID: 33862107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.
    Vida M; Gavito AL; Pavón FJ; Bautista D; Serrano A; Suarez J; Arrabal S; Decara J; Romero-Cuevas M; Rodríguez de Fonseca F; Baixeras E
    Dis Model Mech; 2015 Jul; 8(7):721-31. PubMed ID: 26035386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quercetin inhibition of SREBPs and ChREBP expression results in reduced cholesterol and fatty acid synthesis in C6 glioma cells.
    Damiano F; Giannotti L; Gnoni GV; Siculella L; Gnoni A
    Int J Biochem Cell Biol; 2019 Dec; 117():105618. PubMed ID: 31542428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
    Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
    J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chitosan oligosaccharide attenuates hepatic steatosis in HepG2 cells via the activation of AMP-activated protein kinase.
    Li T; Gong H; Zhan B; Mao X
    J Food Biochem; 2022 May; 46(5):e14045. PubMed ID: 35187676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxyresveratrol ameliorates nonalcoholic fatty liver disease by regulating hepatic lipogenesis and fatty acid oxidation through liver kinase B1 and AMP-activated protein kinase.
    Lee JH; Baek SY; Jang EJ; Ku SK; Kim KM; Ki SH; Kim CE; Park KI; Kim SC; Kim YW
    Chem Biol Interact; 2018 Jun; 289():68-74. PubMed ID: 29702089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD).
    Araújo S; Soares E Silva A; Gomes F; Ribeiro E; Oliveira W; Oliveira A; Lima I; Lima MDC; Pitta I; Peixoto C
    Eur J Pharmacol; 2016 Oct; 788():306-314. PubMed ID: 27349145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary long-chain unsaturated fatty acids acutely and differently reduce the activities of lipogenic enzymes and of citrate carrier in rat liver.
    Gnoni A; Giudetti AM
    J Physiol Biochem; 2016 Sep; 72(3):485-94. PubMed ID: 27312217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway.
    Kim DE; Chang BY; Jeon BM; Baek JI; Kim SC; Kim SY
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melatonin Modulates lipid Metabolism in HepG2 Cells Cultured in High Concentrations of Oleic Acid: AMPK Pathway Activation may Play an Important Role.
    Mi Y; Tan D; He Y; Zhou X; Zhou Q; Ji S
    Cell Biochem Biophys; 2018 Dec; 76(4):463-470. PubMed ID: 30324559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma.
    Lally JSV; Ghoshal S; DePeralta DK; Moaven O; Wei L; Masia R; Erstad DJ; Fujiwara N; Leong V; Houde VP; Anagnostopoulos AE; Wang A; Broadfield LA; Ford RJ; Foster RA; Bates J; Sun H; Wang T; Liu H; Ray AS; Saha AK; Greenwood J; Bhat S; Harriman G; Miao W; Rocnik JL; Westlin WF; Muti P; Tsakiridis T; Harwood HJ; Kapeller R; Hoshida Y; Tanabe KK; Steinberg GR; Fuchs BC
    Cell Metab; 2019 Jan; 29(1):174-182.e5. PubMed ID: 30244972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SeP is elevated in NAFLD and participates in NAFLD pathogenesis through AMPK/ACC pathway.
    Chen Y; He X; Chen X; Li Y; Ke Y
    J Cell Physiol; 2021 May; 236(5):3800-3807. PubMed ID: 33094480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.